Gallardo F, Mogas T, Baró T, Rabanal R, Morote J, Abal M, Reventós J, Lloreta J
Departament de Medicina i Cirurgia Animals, Facultat de Veterinaria, Universitat Autònoma de Barcelona, Barcelona, Spain.
J Comp Pathol. 2007 Jan;136(1):1-8. doi: 10.1016/j.jcpa.2006.08.007. Epub 2006 Oct 31.
The expression of receptor for androgen (AR), oestrogen alpha and beta (ERalpha and ERbeta) and progesterone (PR) was examined immunohistochemically in canine prostate specimens (normal, hyperplastic, inflamed [prostatitis] or neoplastic). AR immunolabelling was seen in 100% of epithelial cells of normal and hyperplastic tissue, the corresponding figures for inflamed and carcinomatous tissue being 74% and 65%, respectively. ERalpha labelling was seen in 85% of epithelial cells in normal prostate glands, the corresponding figures for hyperplastic, inflamed and neoplastic glands being 35%, 22% and 12%, respectively. ERbeta labelling was seen in 85% of epithelial cells of normal glands and in about 70% of such cells in glands showing pathological changes. On the other hand, PR expression (weak) in normal glands was observed in fewer epithelial cells (44%) than in hyperplastic (70%), inflamed (62%) or neoplastic (64%) glands.
采用免疫组织化学方法检测了犬前列腺标本(正常、增生、炎症[前列腺炎]或肿瘤)中雄激素受体(AR)、雌激素α和β(ERα和ERβ)以及孕激素受体(PR)的表达情况。在正常和增生组织的100%上皮细胞中可见AR免疫标记,炎症组织和癌组织中的相应比例分别为74%和65%。在正常前列腺腺上皮细胞的85%中可见ERα标记,增生、炎症和肿瘤性腺上皮细胞中的相应比例分别为35%、22%和12%。在正常腺上皮细胞的85%以及出现病理变化的腺上皮细胞的约70%中可见ERβ标记。另一方面,正常腺体中PR表达(较弱)在上皮细胞中的比例(44%)低于增生(70%)、炎症(62%)或肿瘤(64%)腺体。